The Pennant Group Inc (PNTG) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


The Pennant Group Inc   (NASDAQ: PNTG)


The Pennant Group Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is The Pennant Group Inc 's ROA in the second quarter of 2026?
The Pennant Group Inc achieved a return on average assets (ROA) of 4.1 % in its second quarter of 2026, this is above PNTG's average return on assets of 2.56%.
The Pennant Group Inc assets over the 12 months ending in its second quarter of 2026 are valued at $937 million

ROA fell compared to the first quarter of 2026, despite the net income growth of 5.88% from the first quarter of 2026.

However, within the Healthcare sector 170 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 1336, from total ROA ranking in the first quarter of 2026 at 1559.

What is ROA?



Return On Assets (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Total Assets Change 38.93 % 28.62 % 142.1 % 96.22 % 122.31 %
Y / Y Net Income Change 36.55 % 20.78 % 58.88 % 3.44 % 30.96 %
Net Income (TTM) in million 38 36 34 30 30
Return On Assets (TTM) 4.1 % 4.11 % 4.16 % 4.5 % 5.19 %
PNTG's Total Ranking # 1336 # 1559 # 1341 # 1315 # 1340
Total Assets (TTM) in million 1,044 956 995 754 751
Seq. Total Assets Change 9.14 % -3.86 % 32.01 % 0.3 % 1.05 %
Seq. Net Income Change 5.88 % -0.79 % 50.67 % -13.72 % -6.35 %



Return On Assets Company Ranking
Within: No.
Industry # 49
Sector # 171
Overall # 1330

Return On Assets Statistics
High Average Low
4.21 %
2.56 %
-0.52 %
(Jun 30 2025)   (Jun 30 2022)





Financial Statements
The Pennant Group Inc 's Assets $ 1,044 million PNTG's Balance sheet
The Pennant Group Inc 's Income $ 11 million Quarterly PNTG's Income Statement
PNTG's Income by Division See PNTG's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025
(Dec 31 2024)
FY 2024
(Dec 31 2023)
FY 2023
(Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
Y / Y Total Assets Change 142.1 % 47.41 % 9.28 % 9.27 % 16.01 %
Total Assets in million 995 411 279 255 233
Y / Y Net Income Change 38.72 % 74.97 % 92.05 % 237.2 % -86.19 %
Net Income in million 34 24 14 7 2
Annual Return On Assets 3.39 % 5.92 % 4.99 % 2.84 % 0.92 %




Comment on PNTG's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA deteriorated to 3.39 %, despite annual net income growth of 38.72 % to $33.76 million, from $24.34 million a year ago, as PNTG's assets increase to $994.86 million, by 38.72 %.


More Return On Assets Ratios
PNTG's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PNTG's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PNTG's Competitors
Subscribers only: Roa for The Pennant Group Inc 's Suppliers
Subscribers only: Return On Assets for PNTG's Customers

You may also want to know
PNTG's Roi PNTG's Inventory Turnover Ratio PNTG's Growth Rates PNTG's Dividend Comparisons
PNTG's Profitability Ratios PNTG's Asset Turnover Ratio PNTG's Dividend Growth
PNTG's Roe PNTG's Valuation Ratios PNTG's Financial Strength Ratios PNTG's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Protagonist Therapeutics inc   11.02 %
Agilent Technologies inc   10.97 %
Prestige Consumer Healthcare Inc   10.90 %
Lemaitre Vascular Inc   10.90 %
Ufp Technologies Inc   10.85 %
Progyny Inc   10.66 %
Regeneron Pharmaceuticals Inc   10.60 %
Johnson and Johnson  10.60 %
Tenet Healthcare Corp  10.49 %
Bristol myers Squibb Company  10.27 %
Solventum Corporation  10.13 %
Globus Medical Inc   10.04 %
Universal Health Services Inc   9.92 %
Entrada Therapeutics Inc   9.51 %
Amgen Inc   9.48 %
National Healthcare Corp  9.28 %
Tactile Systems Technology Inc   9.17 %
Bioventus Inc   9.08 %
Infusystem Holdings Inc  8.63 %
Penumbra Inc  8.63 %
Utah Medical Products Inc  8.50 %
Boston Scientific Corporation  8.34 %
3m Company  8.27 %
Jazz Pharmaceuticals Plc  8.19 %
Pediatrix Medical Group Inc   8.09 %
Veracyte Inc   8.04 %
Stryker Corp  7.89 %
Lifevantage Corp  7.87 %
Embecta Corp   7.82 %
Beone Medicines Ltd   7.82 %


Date modified: 2026-09-08T15:11:45+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.